NUCLEICA was founded by Orsifor in partnership with three biomedical scientists with an international career in some of the top institutions in Europe (Institut Pasteur and Cambridge University) and the US (The Rockefeller University). Orsifor financed the creation of our new laboratory and brings the management experience of one of Portugal’s top-performing SMEs. Our scientific team has decades of hands-on experience in gene editing and has engineered cell lines for several leading research institutes.

Our mission is to deliver affordable, high-quality gene-editing services and to develop innovative products in this rapidly evolving field. We offer a range of service tiers designed to match the budgets and needs of academic researchers, and we provide a unique option for biotech companies: a fully customised service based on off-patent techniques that produces edited cell lines completely free of royalties.